Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD44 antibody

This anti-CD44 antibody is a Mouse Monoclonal antibody detecting CD44 in FACS, WB, IHC, IF, Func and IHC (f). Suitable for Human.
Catalog No. ABIN6936715

Quick Overview for Recombinant CD44 antibody (ABIN6936715)

Target

See all CD44 Antibodies
CD44

Antibody Type

Recombinant Antibody

Reactivity

  • 332
  • 138
  • 75
  • 31
  • 30
  • 29
  • 26
  • 22
  • 14
  • 13
  • 7
  • 7
  • 7
  • 5
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 195
  • 138
  • 73
  • 2
  • 1
  • 1
Mouse

Clonality

  • 293
  • 112
  • 3
Monoclonal

Conjugate

  • 179
  • 40
  • 29
  • 25
  • 16
  • 7
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD44 antibody is un-conjugated

Application

  • 283
  • 174
  • 121
  • 72
  • 72
  • 64
  • 61
  • 39
  • 39
  • 31
  • 30
  • 30
  • 14
  • 6
  • 6
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Functional Studies (Func), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

RHCAM-918
  • Specificity

    Recognizes a cell surface glycoprotein of 80-95 kDa (CD44) on lymphocytes, monocytes, and granulocytes (Leucocyte Typing Workshop V). Its epitope is resistant to digestion by trypsin and chymotrypsin. This MAb selectively interferes with lymphocyte binding to lymph node, mucosal and synovial endothelium. The CD44 family of glycoproteins exists in a number of variant isoforms, the most common being the standard 85-95 kDa or hematopoietic variant (CD44s). Higher molecular weight isoforms are described in epithelial cells (CD44v), which are believed to function in intercellular adhesion and stromal binding. CD44 immunostaining is commonly used for the discrimination of urothelial transitional cell carcinoma in-situ from non-neoplastic changes in the urothelium.

    Cross-Reactivity (Details)

    Human, Baboon, and Green Monkey.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant full-length human CD44 protein

    Isotype

    IgG1 kappa
  • Application Notes

    Known_Application: Functional Studies (Order Ab without BSA & Azide), Flow Cytometry (1-2 μg/million cells), ,Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), ,Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa cells (FACS). HeLa cell lysate (WB). Paracortex in tonsil or lymph node (IHC).

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    CD44

    Alternative Name

    CD44

    Background

    LHR, BA-1, chondroitin sulfate proteoglycan 8 (CSPG8), Epican, Extracellular Matrix Receptor III (ECM III), GP90 Lymphocyte Homing Adhesion Receptor, HCELL, hematopoietic cell E- and L-selectin ligand, Heparan Sulfate Proteoglycan, Hermes Antigen, HAS, HUTCH I, Hyaluronate Receptor, Indian blood group,CD44 / HCAM Std. (Cancer Stem Cell Marker)
    Cellular localisation: Cell Surface

    Molecular Weight

    80-95kDa

    Gene ID

    960, 502328

    UniProt

    P16070

    Pathways

    Glycosaminoglycan Metabolic Process, Autophagy, Negative Regulation of intrinsic apoptotic Signaling
You are here:
Chat with us!